Ticker > Company >

Chandan Healthcare share price

Chandan Healthcare Ltd.

  7.33 K   6   0 NSE: CHANDAN SECTOR: Hospital & Healthcare Services

238.40
-2.25 (-0.94%)
NSE: 16 Oct 03:31 PM

Price Summary

Today's High

₹ 244

Today's Low

₹ 236.05

52 Week High

₹ 358

52 Week Low

₹ 185.4

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 582.94 Cr.

Enterprise Value

₹ 618.82 Cr.

No. of Shares

2.45 Cr.

P/E

23

P/B

3.37

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  70.75

CASH

₹ 3.14 Cr.

DEBT

₹ 39.02 Cr.

Promoter Holding

47.2 %

EPS (TTM)

₹  10.36

Sales Growth

21.28%

ROE

17.66 %

ROCE

21.28%

Profit Growth

21.96 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year21.28%
3 Year27.36%
5 YearNA

Profit Growth

1 Year21.96%
3 Year84.4%
5 YearNA

ROE%

1 Year17.66%
3 Year30.33%
5 Year20.67%

ROCE %

1 Year21.28%
3 Year30.17%
5 Year22.81%

Debt/Equity

0.2347

Price to Cash Flow

24.12

Interest Cover Ratio

8.655

CFO/PAT (5 Yr. Avg.)

0.69134487635866

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2026 47.20 0.00
Jun 2026 49.61 0.00
Mar 2026 49.55 0.00
Dec 2025 49.47 0.00
Sep 2025 49.47 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 84.3989825628193% for the Past 3 years.
  • The company has shown a good revenue growth of 27.3560981580535% for the Past 3 years.
  • Company has been maintaining healthy ROE of 30.3316% over the past 3 years.
  • Company has been maintaining healthy ROCE of 30.1677666666667% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 8.655.
  • The Company has been maintaining an effective average operating margins of 20.13442% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -476.6463 days.
  • Company has a healthy liquidity position with current ratio of 3.5291.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.00195659354021.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2025 Mar 2026 Jun 2026
Net Sales 35.7 44.77 48.67
Total Expenditure 25.68 33.47 31.56
Operating Profit 10.01 11.3 17.11
Other Income 0.68 2 1.09
Interest 0.94 1.37 4.06
Depreciation 2.37 2.34 4.18
Exceptional Items -2.07 -0.65 0
Profit Before Tax 5.32 8.95 9.96
Tax 1.35 2.13 3.25
Profit After Tax 3.96 6.82 6.71
Adjusted EPS (Rs) 1.62 2.79 2.74

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 71.6 75.83 99.87 129.16 156.65
Total Expenditure 67.79 66.52 74.44 93.06 110.22
Operating Profit 3.81 9.31 25.44 36.11 46.43
Other Income 0.2 0.09 1 2.05 4.13
Interest 2.32 2.08 2.11 3.57 4.43
Depreciation 1.95 2.05 3.36 6.42 9.51
Exceptional Items 0 0 0 0 -2.71
Profit Before Tax -0.26 5.27 20.96 28.17 33.9
Tax 0.66 1.22 4.95 7.39 8.56
Net Profit -0.71 4.04 16.02 20.78 25.34
Adjusted EPS (Rs.) -0.46 2.02 8.01 8.5 10.36

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 20 20 20 24.45 24.45
Total Reserves 2.61 6.65 20.67 96.26 142.94
Borrowings 6.69 7.89 12.18 22.14 28.97
Other N/C liabilities 1.17 3.54 4.36 5.06 6.52
Current liabilities 29.03 31.6 35.92 28.98 29.43
Total Liabilities 59.5 69.68 93.12 176.9 232.31
Assets
Net Block 24.81 27.73 43.53 71.48 95.74
Capital WIP 0 0 0 4.1 11.9
Intangible WIP 0 0 0 0 0
Investments 14.12 2.23 10.32 25.99 17.79
Loans & Advances 1.35 4.38 2 2.22 3.02
Other N/C Assets 0 2.96 2.39 0 0
Current Assets 19.21 32.39 34.89 73.11 103.85
Total Assets 59.5 69.68 93.12 176.9 232.31
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 0 5.27 20.96 28.17 33.9
Adjustment 0 5.04 5.47 9.53 11.45
Changes in Assets & Liabilities 0 -0.67 -17 -23.93 -12.63
Tax Paid 0 -0.91 -3.59 -7.39 -8.56
Operating Cash Flow 0 8.73 5.85 6.38 24.16
Investing Cash Flow 0 -6.19 -15.36 -60.86 -49.85
Financing Cash Flow 0 -2 8.51 59.99 22.79
Net Cash Flow 0 0.54 -1.01 5.5 -2.9

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2024

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q2FY26
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY26
Presentation Q3FY26
Presentation Q1FY27
Presentation Q1FY26

Company News

Chandan Healthcare Stock Price Analysis and Quick Research Report. Is Chandan Healthcare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Chandan Healthcare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Chandan Healthcare has a PE ratio of 23.0033675231819 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Chandan Healthcare has ROA of 12.3854% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Chandan Healthcare has a Current ratio of 3.5291.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Chandan Healthcare has a ROE of 17.6597%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Chandan Healthcare has a Debt to Equity ratio of 0.2347 which means that the company has low proportion of debt in its capital.

  • Sales growth: Chandan Healthcare has reported revenue growth of 21.2776% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Chandan Healthcare for the current financial year is 29.6406002529249%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Chandan Healthcare is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Chandan Healthcare is Rs 10.3637. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Chandan Healthcare in Ticker for free. Also, one can get the intrinsic value of Chandan Healthcare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Chandan Healthcare FAQs

Q1. What is Chandan Healthcare share price today?
Ans: The current share price of Chandan Healthcare is Rs 238.4.

Q2. What is the market capitalisation of Chandan Healthcare?
Ans: Chandan Healthcare has a market capitalisation of Rs 582.93720576 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Chandan Healthcare?
Ans: The PE ratio of Chandan Healthcare is 23.0033675231819 and the P/B ratio of Chandan Healthcare is 3.36980182625166, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Chandan Healthcare share?
Ans: The 52-week high share price of Chandan Healthcare is Rs 358, and the 52-week low share price of Chandan Healthcare is Rs 185.4.

Q5. Does Chandan Healthcare pay dividends?
Ans: Currently, Chandan Healthcare does not pay dividends. Dividend yield of Chandan Healthcare is around 0%.

Q6. What are the face value and book value of Chandan Healthcare shares?
Ans: The face value of Chandan Healthcare shares is Rs 10, while the book value per share of Chandan Healthcare is around Rs 70.746. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Chandan Healthcare?
Ans: Chandan Healthcare has a total debt of Rs 39.0223 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Chandan Healthcare?
Ans: The ROE of Chandan Healthcare is 17.6597% and ROCE of Chandan Healthcare is 21.2759%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Chandan Healthcare a good buy for the long term?
Ans: The Chandan Healthcare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Chandan Healthcare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Chandan Healthcare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Chandan Healthcare’s financials?
Ans: You can review Chandan Healthcare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Chandan Healthcare
X